ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Methoxsalen

Also written as “methoxsalen”, “ECP Methoxsalen” and “Methoxsalen +ECP”.

Its studies are mostly in Graft vs Host Disease · Colitis · Melanoma · Bronchiolitis Obliterans Syndrome · Crohn Disease, led by 4 companies.

Drug pageMethoxsalen: every studyAll 19 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since Feb 5, 20039 company-led studies, 1 open or runningNext primary completion: Dec 2028 (phase 2)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Keenova Therapeuticsits history only50 open or runningphase 2since Feb 5, 2003Feb 5, 2003none ahead
Therakosits history only21 open or runningphase 2since Oct 15, 2024Oct 15, 2024Dec 2028phase 2 · NCT07619898
Therakos10 open or runningno phasesince Nov 2, 1999Nov 2, 1999none ahead
Therakos, Inc., a Mallinckrodtits history only10 open or runningphase 3since Aug 13, 2015Aug 13, 2015none ahead

Also a collaborator on its studies: Parexel and ICON.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Therakos only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 2, 1999First study: no phase study in HIV InfectionsFirst studyNCT00002011 · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Therakos leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT00002011HIV Infections · United States–Completed

How it is read

Names in the registry

  • “Methoxsalen”, 6 entries
  • “methoxsalen”, 1 entry
  • “ECP Methoxsalen”, 1 entry
  • “Methoxsalen +ECP”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.